You are here: Industry Insights > depression

News List

Good News for People with Persistent Anxiety drugs
January 15, 2020
A diagnosis of generalized anxiety disorder need not be a life sentence, a large Canadian study suggests."It's so exciting," said lead author Esme Fuller-Thomson, director of the Institute for Life Course and Aging at the University of Toronto.
Phytomedicine Saffron in The Treatment of Depression and It’s Potential Effects Lin Zhang
January 15, 2020
There has been an increasing studies on Saffron use in medical condition within the last two decades.
Mental Distress, Depression Prevalent in Adults With Arthritis drugs
January 03, 2020
The prevalence of mental distress is 16.8 percent and the prevalence of depression is 32.1 percent among adults with arthritis ...
Depression May Worsen QOL in Rheumatoid Arthritis Patients drugs
December 30, 2019
Patients with coexisting rheumatoid arthritis (RA) and depression tend to have higher disease activity and lower quality of life than patients without depression ...
Could Brain Scans Spot Children's Mood, Attention Problems Early? drugs
December 27, 2019
Children's mental health issues are hard to predict until they're causing problems, but researchers may have found a way to use brain scans to spot which kids are at risk for depression ...
Single Antidepressant Dose of Intravenous Ketamine Safe drugs
December 26, 2019
A single, low-dose ketamine infusion is relatively free of side effects for patients with treatment-resistant depression, according to research recently published in the Journal of Affective Disorders.
One-Third of Lung Cancer Patients Battle Depression: Study drugs
December 25, 2019
Depression is common among lung cancer patients and can damage their quality of life and treatment outcomes, a new study indicates.The findings suggest that doctors should screen lung cancer patients for depression and refer them for mental health care if
Takeda and Lundbeck’s Trintellix approved in Japan for depression pharmaceutical-technology
September 25, 2019
Takeda has announced that its drug Trintellix (vortioxetine) has been approved by the Japanese Ministry of Health, Labour and Welfare for the treatment of depression and depressed state.
Hysterectomy Tied to Long-Term Risk for Depression, Anxiety drugs
September 19, 2019
According to a study published online in Menopause, hysterectomy, even with ovarian conservation, is associated with an increased long-term risk for de novo depression.
Hysterectomy Tied to Depression, Anxiety drugs
September 18, 2019
Having a hysterectomy can be a traumatic experience, and new research now shows it may also increase the long-term risk for depression and anxiety.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page